NCT05817695 (MICRA-SYNK) is a clinical trial of Leadless pacemaker in Bradycardia, sponsored by First People's Hospital of Hangzhou.

Who is sponsoring NCT05817695?

NCT05817695 is sponsored by First People's Hospital of Hangzhou.

What drugs are being tested in NCT05817695?

Interventions in NCT05817695: Leadless pacemaker.

What condition does NCT05817695 study?

NCT05817695 studies Bradycardia.

Is NCT05817695 still recruiting?

NCT05817695 is currently status unknown. Last updated 18 April 2023.

Last reviewed 2023-04-18 · How we verify

NCT05817695: MICRA-SYNK

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cardiac Synchronization and Tricuspid Regurgitation With Leadless Pacemaker

Status unknown Last updated 18 April 2023

What this trial tests

trial testing Leadless pacemaker in Bradycardia in 40 participants. Status unknown.

Timeline

1 March 2022

Primary endpoint
1 May 2023

31 May 2023

Quick facts

Lead sponsor	First People's Hospital of Hangzhou
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	40
Start date	1 March 2022
Primary completion	1 May 2023
Estimated completion	31 May 2023
Sites	1 location across China

Drugs / interventions tested

Leadless pacemaker

Conditions studied

Bradycardia — all drugs for Bradycardia →

Sponsor

First People's Hospital of Hangzhou

Who can join

Eligibility, any sex, with Bradycardia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison of cardiac synchronization and tricuspid regurgitation with or without leadless pacemaker pacing in different site

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Impact of leadless pacemaker implantation site on cardiac synchronization and tricuspid regurgitation.
Gao XF, Zhu H, Zhang JS, Ning-Zhang, et al · · 2025 · cited 1× · PMID 39760893 · DOI 10.1186/s43044-024-00602-2

Verify or expand the search:

Other trials of Leadless pacemaker

Trials testing the same drug.

NCT06692218 — Leadless Pacemaker Implantation Positions and Its Relationship with Procedure Efficacy and Complication · NA · recruiting
NCT05761821 — Key Factors of Leadless Pacemaker Implantation With Implantation Site, Complications and Prognosis · unknown

Other recruiting trials for Bradycardia

Currently open trials in the same condition.

NCT07209852 — Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up · recruiting
NCT07254013 — Left Bundle Branch Area Pacing (LBBAP) Monitoring Assistant: Evaluation of Portable ECG Solution · NA · recruiting
NCT07166614 — Dexmedetomidine vs Propofol in High-Risk ERCP Patients · NA · recruiting
NCT07585799 — Permanent Conduction System Pacing Versus Atrioventricular Management for Patients With Wide QRS and Patent AV Conductio · NA · recruiting
NCT07217392 — Left Bundle Branch Area Pacing (LBBAP) PMCF Study · NA · recruiting

Other First People's Hospital of Hangzhou trials

Trials by the same sponsor.

NCT07507825 — Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG) · Phase 2 · not yet recruiting
NCT07390981 — Intradermal Acupuncture for Assisting SSRI Dose Reduction in Major Depressive Disorder · NA · not yet recruiting
NCT07242443 — Tegoprazan Plus Amoxicillin BID vs TID Regimens for H. Pylori Eradication（Frequency Adjusted Same-dose Therapy for H. Py · Phase 4 · not yet recruiting
NCT07207278 — Multi Omics Molecular Characteristics and Immunophenotyping of Lung Signet Ring Cell Carcinoma · recruiting
NCT06933992 — Safety and Efficacy of Chocolate Balloon Catheter in Peripheral Arterial Disease (CHOCO-PAD) · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05817695 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by First People's Hospital of Hangzhou
Last refreshed: 18 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05817695.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing